SCHEMBL26057058

SCHEMBL26057058

Ic1ccccc1-c1cccc2c1[nH]c1ccc3c4ccc5[nH]c6ccccc6c5c4oc3c12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GABRA1 P14867 3/20 0.47
▸ GABRG2 P18507 3/20 0.47
▸ GABRB3 P28472 3/20 0.47
▸ GABRA5 P31644 3/20 0.47
▸ GABRA3 P34903 3/20 0.47
▸ GABRA2 P47869 3/20 0.47
▸ GABRP O00591 2/20 0.47
▸ GABRD O14764 2/20 0.47
▸ GABRB1 P18505 2/20 0.47
▸ GABRB2 P47870 2/20 0.47
▸ GABRA4 P48169 2/20 0.47
▸ GABRE P78334 2/20 0.47
▸ GABRA6 Q16445 2/20 0.47
▸ GABRG1 Q8N1C3 2/20 0.47
▸ GABRG3 Q99928 2/20 0.47
▸ GABRQ Q9UN88 2/20 0.47
▸ CDK4 P11802 5/20 0.40
▸ CCND1 P24385 5/20 0.40
▸ IMPDH2 P12268 1/20 0.38
▸ IMPDH1 P20839 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16484309 0.80 GABRA1 (0.58) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL28615344 0.77 PARP14 (0.52) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL24417328 0.77 GABRP (0.45) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL14951613 0.74 GABRA1 (0.51) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL18621478 0.74 GABRA1 (0.61) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL28909046 0.73 CDK4 (0.41) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL21600432 0.73 GABRP (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL19573737 0.72 CDK4 (0.50) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL31846 0.71 GABRA1 (0.51) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL29819648 0.71 GABRA1 (0.51) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230322673-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-10-12 — — US disclosed
US-11739061-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device IDEMITSU KOSAN CO., LTD (JP) 2023-08-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230322673-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE L1CAM, CCNL2, CTNND1 GABRA1 4273/4885GABRG2 4158/4885GABRB3 3977/4885
US-11739061-B2 Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device L1CAM, CCNL2, CTNND1 GABRA1 4273/4885GABRG2 4158/4885GABRB3 3977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback